Condition

Vasomotor Symptoms clinical trials and research

• 9Clinical trials
• 4Countries

Newest Vasomotor Symptoms clinical trials

All recruiting trials (9)

• Wearable cooling device to ease hot flashes in men on ADT for prostate cancer

  A randomized test to see if the Embr Wave wearable can reduce hot flashes in men with prostate cancer on androgen deprivation therapy.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07729150

• Fezolinetant for hot flashes in men on hormone therapy for prostate cancer

  This study tests whether fezolinetant can reduce vasomotor symptoms in men receiving androgen deprivation therapy for prostate cancer.

  Recruiting Phase 2 Chinese University of Hong Kong · Shatin · NCT07568236

• Acupuncture to ease hot flashes in men on hormone therapy for prostate cancer

  This trial will test if weekly acupuncture plus lifestyle education can help reduce hot flashes and related symptoms in men receiving androgen deprivation therapy for prostate cancer.

  Recruiting Inova Health Care Services · Fairfax, Virginia · NCT07335224

• JDS-HF3.0 supplement to ease menopause symptoms in postmenopausal women

  This trial will see if taking two JDS-HF3.0 tablets each morning for 12 weeks can reduce hot flashes, night sweats, and joint discomfort in postmenopausal women aged 50–70.

  Recruiting Bonafide Health · Harrison, New York · NCT07238478

• CL25216 for perimenopausal hot flashes and night sweats

  We will test whether taking one 250 mg capsule of CL25216 daily for 105 days reduces hot flashes and night sweats in perimenopausal women aged 40–55.

  Recruiting ApexCPG LLC · Vijayawada · NCT07112651

• Asimadoline for moderate to severe menopausal hot flashes in midlife women

  This trial tests whether the drug asimadoline reduces moderate to severe menopausal vasomotor symptoms (hot flashes) in perimenopausal and postmenopausal women aged 40–62.

  Recruiting Phase 2 Tioga Pharmaceuticals · Atlanta, Georgia · NCT07042516

• Fezolinetant to reduce hot flashes in men on androgen-deprivation therapy

  This trial will test whether taking fezolinetant once daily for 4 weeks reduces how often and how severe hot flashes are in men with prostate cancer who are on androgen-deprivation therapy.

  Recruiting Phase 2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06957691

• Fezolinetant to reduce hot flashes in men on androgen-deprivation therapy

  This trial will test whether taking fezolinetant once daily for 4 weeks reduces how often and how severe hot flashes are in men with prostate cancer who are on androgen-deprivation therapy.

  Recruiting Phase 2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06957691

• Comparing Lemborexant, Zopiclone, and Clonidine for treating insomnia in chronic pain patients

  This study is testing whether Lemborexant, Zopiclone, or Clonidine can help people with chronic pain sleep better and manage their pain.

  Recruiting Salem Anaesthesia Pain Clinic · Surrey, British Columbia · NCT05618002

Related topics

Quick answers

How many Vasomotor Symptoms clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (6 trials), Hong Kong (1 trial), Canada (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →